2015
DOI: 10.1038/ejhg.2015.12
|View full text |Cite
|
Sign up to set email alerts
|

Clinical utility gene card for: Nemaline myopathy – update 2015

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 57 publications
0
11
0
Order By: Relevance
“…22 Consequently, shortened thin filaments are likely to be a phenotype that contributes to lower force generation in a large number of patients with thin filament myopathy. The effect of shorter thin filaments on force development is sarcomere- and muscle length–dependent, with a more pronounced effect at greater lengths.…”
Section: Discussionmentioning
confidence: 99%
“…22 Consequently, shortened thin filaments are likely to be a phenotype that contributes to lower force generation in a large number of patients with thin filament myopathy. The effect of shorter thin filaments on force development is sarcomere- and muscle length–dependent, with a more pronounced effect at greater lengths.…”
Section: Discussionmentioning
confidence: 99%
“…Over 140 recessive variants have been identified in nebulin (499). Due to the heterogeneity of nemaline myopathy pathology and the large size of nebulin, it has been difficult to study the role of this protein in disease development.…”
Section: Sarcomere—the Basic Contractile Unit Of Striated Musclementioning
confidence: 99%
“…The most common is Duchenne muscular dystrophy (DMD), which is an X-linked recessive disease that affects 1 in 3500 to 5000 males [reviewed in (438)]. Another example is nemaline myopathy, which affects 1 in 50,000 births [reviewed in (499)]. Advances in next generation sequencing have identified numerous mutations in humans.…”
Section: Introductionmentioning
confidence: 99%
“…In contrast to the phenotypic variability caused by NEB or ACTA1 mutations, KLHL40 mutations are always associated with a poor prognosis (average age of death is 5 months), and prenatal presentations have been documented in greater than 80% of cases . Seven other genetic loci and additional cases of NM not linked to any of the known loci have been identified, with variable clinical presentations .…”
Section: Nemaline Myopathymentioning
confidence: 99%